Elequin Capital
ELV icon

Elequin Capital’s Elevance Health ELV Stock Holding History

Elequin Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-189
Closed -$73.1K – 894
2026
Q2 		$73.1K Buy
+189
New +$70.1K ﹤0.01% 280
2022
Q2 		– Sell
-9
Closed -$4K – 407
2022
Q1 		$4K Sell
9
-2
-18% -$914 ﹤0.01% 225
2021
Q4 		$5K Buy
+11
New +$4.63K ﹤0.01% 17

Other funds holding ELV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Elequin Capital's ELV Position: Q3 2026 in Review

Elequin Capital sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 189 shares — an estimated $73.1K sold.

Elequin Capital first reported a position in ELV in Q4 2021 and held it in 3 quarters. The position peaked at $73.1K in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Elequin Capital reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
  • Elequin Capital sold 189 Elevance Health shares in Q3 2026, an estimated $73.1K.
  • Elequin Capital first reported a position in Elevance Health in Q4 2021 and held it in 3 quarters.
  • Elequin Capital's Elevance Health position peaked at $73.1K in Q2 2026.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Elequin Capital's 13F filing for Q3 2026, filed 13 Nov 2026.